Evidence map›Paper›PMID 36400806›Full record

ArticleScientific reports2022

Spatiotemporal dynamics of Plasmodium falciparum histidine-rich protein 2 and 3 deletions in Peru.

Hugo O Valdivia, Karen Anderson, David Smith, Cielo Pasay, Carola J Salas, Greys Braga, Carmen M Lucas, Stephen E Lizewski, Christie A Joya, Jennifer M Kooken and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Malaria control and the unexpected spread of diagnostic-resistantbioRxiv : the preprint server for biology · 2026
    Article
  4. Local variability inMalariaWorld journal · 2026
    Article
  5. Field evaluation of a loop-mediated isothermal amplification test for detection ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Hugo O ValdiviaU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Karen AndersonAustralia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
David SmithAustralia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Cielo PasayAustralia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Carola J SalasU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Greys BragaU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Carmen M LucasU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Stephen E LizewskiU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Christie A JoyaU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Jennifer M KookenAustralia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Juan F SanchezU.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru. juan.sanchez209.ln@health.mil.
Qin ChengAustralia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia. Qin.Cheng@defence.gov.au.
Naval Medical Research Unit Six · PEQIMR Berghofer Medical Research Institute · AUWalter Reed Army Institute of Research · US

Funding

US DoD Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Branch P0014_21_AFUS DoD Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Branch P0074_21_N6
6 · The paper itself

Abstract

Peru was the first country where pfhrp2 and pfhrp3 gene deletions were detected despite the fact that rapid diagnostics tests are not commonly used for confirmatory malaria diagnosis. This context provides a unique scenario to study the dynamics of pfhrp2 and pfhrp3 gene deletions without apparent RDTs selection pressure. In this study we characterized the presence of pfhrp2 and pfhrp3 genes on 325 P. falciparum samples collected in Iquitos and surrounding communities between 2011 and 2018 in order to understand the dynamics of gene deletion prevalence, potential associations with clinical symptomatology and parasite genetic background. P. falciparum presence was confirmed by microscopy and PCR of 18 s rRNA, pfmsp1 and pfmsp2. Gene deletions were assessed by amplification of exon1 and exon2 of pfhrp2 and pfhrp3 using gene specific PCRs. Confirmation of absence of HRP2 expression was assessed by ELISA of HRP2 and pLDH. Genotyping of 254 samples were performed using a panel of seven neutral microsatellite markers. Overall, pfhrp2 and pfhrp3 dual gene deletions were detected in 67% (217/324) parasite samples. Concordance between pfhrp2 deletion and negligible HRP2 protein levels was observed (Cohen's Kappa = 0.842). Prevalence of gene deletions was heterogeneous across study sites (adjusted p < 0.005) but there is an overall tendency towards increase through time in the prevalence of dual pfhrp2/3-deleted parasites between 2011 (14.3%) and 2016 (88.39%) stabilizing around 65% in 2018. Dual deletions increase was associated with dominance of a single new parasite haplotype (H8) which rapidly spread to all study sites during the 8 study years. Interestingly, participants infected with dual pfhrp2/3-deleted parasites had a significantly lower parasitemias than those without gene deletions in this cohort. Our study showed the increase of pfhrp2/3 deletions in the absence of RDTs pressure and a clonal replacement of circulating lines in the Peruvian Amazon basin. These results suggest that other factors linked to the pfhrp2/3 deletion provide a selective advantage over non-deleted strains and highlight the need for additional studies and continuing surveillance.

Indexed as

Malaria, FalciparumPlasmodium falciparumGene DeletionHistidineHumansPeruHistidine

Identifiers

PMID36400806
PMCPMC9674673
OpenAlexW4309468985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.